Literature DB >> 7579387

Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts.

U Novak1, A G Harpur, L Paradiso, V Kanagasundaram, A Jaworowski, A F Wilks, J A Hamilton.   

Abstract

Colony-stimulating factor 1 (CSF-1) causes the activation of STAT1 and STAT3 transcription factors in bone marrow macrophages (BMM), in the macrophage cell line BAC1.2F5, and in fibroblasts that express the wild-type receptor for CSF-1. Fibroblasts expressing a mutant receptor in which the tyrosine 809 is replaced with phenylalanine do not activate STAT proteins in response to CSF-1. The activation of the STAT proteins in BMM is accompanied by tyrosine phosphorylation of Tyk2. In fibroblasts, the activation of the STAT proteins is accompanied by tyrosine phosphorylation of Tyk2 and JAK1. We propose that these JAK kinases are subjected to very rapid phosphorylation in response to CSF-1, followed by rapid dephosphorylation. Furthermore, we propose that kinases other than JAK kinase may be involved in the phosphorylation of the STAT proteins in response to CSF-1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579387

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  Targeting STAT3 signaling in kidney disease.

Authors:  Jesse Pace; Praharshasai Paladugu; Bhaskar Das; John C He; Sandeep K Mallipattu
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-03

Review 2.  Innate immune regulation by STAT-mediated transcriptional mechanisms.

Authors:  Haiyan S Li; Stephanie S Watowich
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

3.  Tyrosine phosphorylation of proteins in primary human myeloid leukemic cells stimulated by macrophage colony-stimulating factor: analysis by disease type and comparison with normal human hematopoietic cells.

Authors:  S Hagiwara; M Yagisawa; K Saeki; S Iki; A Urabe; T Mimura; A Miwa; A Togawa; M Higashihara; F Takaku; A Yuo
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

4.  Mutational analysis of acute-phase response factor/Stat3 activation and dimerization.

Authors:  J Sasse; U Hemmann; C Schwartz; U Schniertshauer; B Heesel; C Landgraf; J Schneider-Mergener; P C Heinrich; F Horn
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

5.  Separation and characterization of the activated pool of colony-stimulating factor 1 receptor forming distinct multimeric complexes with signalling molecules in macrophages.

Authors:  V Kanagasundaram; A Jaworowski; R Byrne; J A Hamilton
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 6.  STAT3 in the systemic inflammation of cancer cachexia.

Authors:  Teresa A Zimmers; Melissa L Fishel; Andrea Bonetto
Journal:  Semin Cell Dev Biol       Date:  2016-02-06       Impact factor: 7.727

7.  The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.

Authors:  Xuening Wang; Stella Pesakhov; Jonathan S Harrison; Michael Kafka; Michael Danilenko; George P Studzinski
Journal:  Exp Cell Res       Date:  2014-10-16       Impact factor: 3.905

8.  Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes.

Authors:  Tatsuma Okazaki; Satoru Ebihara; Masanori Asada; Shinsuke Yamanda; Yoshifumi Saijo; Yasuyuki Shiraishi; Takae Ebihara; Kaijun Niu; He Mei; Hiroyuki Arai; Tomoyuki Yambe
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 9.  Signal transduction in macrophages: negative regulation for macrophage colony-stimulating factor receptor signaling.

Authors:  Shinya Suzu; Kazuo Motoyoshi
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

Review 10.  Signaling pathways involved in MDSC regulation.

Authors:  Prashant Trikha; William E Carson
Journal:  Biochim Biophys Acta       Date:  2014-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.